603368 柳药集团
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)3.57212.00513.50012.27610.680
总资产报酬率 ROA (%)1.3124.1274.3834.0693.675
投入资产回报率 ROIC (%)1.7585.6255.9755.6015.071

边际利润分析
销售毛利率 (%)12.01911.36611.88911.50511.416
营业利润率 (%)5.8304.7385.0154.6724.395
息税前利润/营业总收入 (%)6.7985.8466.2125.8295.596
净利润/营业总收入 (%)5.2234.0964.3563.9843.741

收益指标分析
经营活动净收益/利润总额(%)110.825101.247104.038104.008102.636
价值变动净收益/利润总额(%)-0.000-0.009-0.0680.8320.264
营业外收支净额/利润总额(%)0.173-0.046-0.0290.0380.211

偿债能力分析
流动比率 (X)1.6381.5701.4911.4891.551
速动比率 (X)1.3881.3471.2921.2621.342
资产负债率 (%)60.86962.68364.96165.79163.424
带息债务/全部投入资本 (%)48.13747.51952.51452.37048.575
股东权益/带息债务 (%)101.785104.03284.17184.62597.040
股东权益/负债合计 (%)61.83857.18950.53348.76054.229
利息保障倍数 (X)7.0985.2655.1835.0444.697

营运能力分析
应收账款周转天数 (天)185.751178.818165.680151.143143.390
存货周转天数 (天)52.49147.44346.80645.55739.983